Table 1.
Study | Model | Target | Effect | Process |
---|---|---|---|---|
Stevenson et al59 | Mice | P- and L-selectin | Inhibition | Metastasis |
Schlesinger et al60 | Mice | VLA-4–VCAM-1 | Inhibition | Metastasis |
Harvey et al61 | Hamster ovarian cells and human breast cancer cells | CXCR4–CXCL12 | Inhibition | Metastasis |
Alyahya et al62 | Mice | E-cadherin | Upregulation | Metastasis |
Bauer et al63 | Mice | von Willebrand factor | Downregulation | Metastasis |
Amirkhosravi et al64 | Mice | TFPI | Upregulation | Metastasis |
Mousa and Mohamed65 | Chick chorioallantoic membrane model | TFPI | Upregulation | Angiogenesis |
Mousa and Mohamed66 | Human umbilical vein endothelial cells | TFPI | Upregulation | Angiogenesis |
Pfankuchen et al67 | Human ovarian cancer cells | Cell surface proteoglycans | Transcriptional reprogramming | Chemoresistance |
Abbreviations: CXCL12, C-X-C motif chemokine ligand 12; CXCR4, C-X-C chemokine receptor type 4; TFPI, tissue factor pathway inhibitor; VCAM-1, vascular cell adhesion molecule-1; VLA-4, very late antigen-4.